Key Collaborators

Key Collaborators2020-11-12T08:56:43+09:30

OUR KEY COLLABORATORS

The CRC for Cell Therapy Manufacturing (CTM CRC) is an international collaboration of 16 participant organisations spanning industry, clinicians, healthcare and research providers.

A $60M investment from the Australian Government and CTM CRC’s participants enables CTM CRC to connect cell biology with advanced materials in a unique approach to address the challenges in regenerative medicine today. Through this, CTM CRC is developing integrated solutions for cost effective, accessible cell therapies.

CTM CRC is part of the Australian Government’s Cooperative Research Centres (CRC) Programme. The CRC Programme aims to foster high-quality research to solve industry-identified issues through industry-led and outcome-focused collaborative research partnerships. Further information about the CRC Programme is available: www.business.gov.au

MTPConnect is a not-for-profit organisation aiming to accelerate the rate of growth of the medical technologies, biotechnologies and pharmaceuticals sector to increase commercialisation, collaboration and establish Australia as an Asia-Pacific hub for MTP companies.

Formed in November 2015 as part of the Federal Government’s Industry Growth Centres Initiative, MTPConnect is an independent and trusted voice, calling for change to support the sector. MTPConnect raises awareness, fosters collaboration and competition, aggregates existing knowledge and shares it with the broader sector. It also jointly funds projects that address the Sector Growth Priorities and the constraints and gaps identified in the sector.

MTPConnect’s mandate as an Industry Growth Centre is focused on four key areas – increasing collaboration and commercialisation across the sector, improving management and workforce skills, improving access to global supply chains and international markets, and optimising the regulatory environment

The MTPConnect Board is led by Dr Bronwyn Evans and includes other respected industry leaders.

Our vision is to ensure that mums, children and their families have access to the very best medical care, facilities and support services at a time when they need it the most.

We are committed to making a difference by providing ongoing support to the Women’s and Children’s Hospital that has a lasting impact on the health and wellbeing of families.

We work in partnership with the Women’s and Children’s Hospital to realise community and donor expectations by investing in the best possible:

  • Medical research
  • Equipment and facilities
  • Hospital environment

Through collaborating on a range of medical research projects, the Women’s & Children’s Hospital Foundation and the Hospital continue to redefine best practice, discovering new treatments and cures that will raise the bar for paediatric healthcare worldwide.

In the last financial year (2016/17), the WCH Foundation raised over $1.5 million towards medical research projects at Hospital.

TechInSA works closely with the South Australia’s start-up companies and entrepreneurs to bring innovative technologies to global markets.

TechInSA is South Australia’s startup support agency, offering customised programs including grants, business and marketing assistance, lab and office space, and access global networks.

Incubate

  • Infrastructure support through two business incubators
  • Co-location with a cluster of 60+ high-growth companies.

Accelerate

  • Business assistance supporting companies towards technology commercialisation
  • Access to international networks

Commercialise

  • Access to funding including grants, venture capital and other finance
  • Connection to investment opportunities in South Australia

As one of USA’s top five pediatric research centers, Seattle Children’s Research Institute is dedicated to providing hope, care and cures to help every child live the healthiest and most fulfilling life possible.

Our investigators are involved in hundreds of projects that cover every phase of research, from studying how diseases work to improving investigational therapies. They have pioneered groundbreaking cystic fibrosis treatments and cutting-edge cancer therapies that help a child’s immune system defeat cancer, and made other major contributions to pediatric medicine.